MoleculeDx, Inc. is a molecular diagnostics company advancing research-driven approaches to cancer detection. Its scientific platform is grounded in more than a decade of peer-reviewed research on cancer-associated fusion genes and fusion transcripts. Through Fusion-detect Technology, MoleculeDx focuses on multi-marker molecular analysis and the study of circulating fusion-transcript signals, supporting evidence-based research in hepatocellular carcinoma and other areas of cancer science.
-
3 Articoli
-
2 Foto
-
0 Video
-
Vive a Pennsylvania
-
Male
-
06/03/1969
-
Seguito da 0 people
Cerca
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek
Aggiornamenti recenti
-
Liver Cancer Screening Blood Test | MoleculeDx, Inc.
Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research.
For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/Liver Cancer Screening Blood Test | MoleculeDx, Inc. Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research. For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/0 Commenti 0 condivisioni 94 Views 0 Anteprima
Altre storie
